Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.

Journal of surgical oncology - 1 Jan 2012

Na Kuk Young, Kim Ra Mi, Song Eun-Mi, Lee Ji Hyun, Lee Jandee, Soh Euy-Young

Abstract excerpt

OBJECTIVES: Approximately 5% of non-medullary thyroid cancer (NMTC) diagnoses are made against a background of familial predisposition and, in such instances, the disease is termed familial non-medullary thyroid cancer (FNMTC). To date, neither genetic alterations causing FNMTC nor genes predisposing to the condition have been described. The objective of the present study was to evaluate loss of heterozygosity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Adenocarcinoma, Papillary

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Family

Share to Loss of Heterozygosity

Share to Polymorphism, Single-Stranded Conformational

Share to ras Proteins

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 21826673
DOI: 10.1002/jso.22064

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.PMID 21826673Read ↗

Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.Semantic proximity Read ↗

Genetic susceptibility to hereditary non-medullary thyroid cancerSemantic proximity Read ↗

Familial nonmedullary thyroid cancer: a review of the genetics.Semantic proximity Read ↗

Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC)Semantic proximity Read ↗

Familial non-medullary thyroid cancer: a critical review.Semantic proximity Read ↗

Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer.Semantic proximity Read ↗

Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.Semantic proximity Read ↗

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.Semantic proximity Read ↗

Familial nonmedullary thyroid carcinoma.Semantic proximity Read ↗

Diagnosis and Management of Hereditary Thyroid Cancer.Semantic proximity Read ↗

Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.Semantic proximity Read ↗

Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.